30th International Symposium on ALS/MND - Perth, Australia - Abstract Book
27-11-2019
- C2 The biomarker challenge - FRANÇAIS
- C3 The fine balance of proteostasis and its implications - FRANÇAIS
- C8 The ALS platform trial - FRANÇAIS
- C20 Modeling ALS - FRANÇAIS
- C26 How frequent are pauses in ALS - FRANÇAIS
- C27 Future directions in ALS genomics - FRANÇAIS
- C32 Designer DNA drug therapy - FRANÇAIS
- C34 An AI drug discovery & C35 Machine learning - FRANÇAIS
- C36 Relevance of CuATSM to sporadic ALS - FRANÇAIS
- C37 Pseudobulbar affect in ALS - FRANÇAIS
- C52 Supporting family carers from diagnosis to bereavemen - FRANÇAIS
- C53 Research and support for young caregivers - FRANÇAIS
- C55 Individual quality of life - FRANÇAIS
- C65 Palliative care and healthcare utilization - FRANÇAIS
- C81 Telehealth provides meaningful contributions to patient care - FRANÇAIS
- C93 Antioxidant drugs reveal the potential for patient stratification - FRANÇAIS
- C94 Intrathecal AAV9-SOD1-shRNA administration - FRANÇAIS
- C95 Loss of appetite is associated with a loss of weight - FRANÇAIS
- C110 The dawn of brain computer interfaces - FRANÇAIS
